Literature DB >> 24151541

The Microenvironment of Cervical Carcinoma Xenografts: Associations with Lymph Node Metastasis and Its Assessment by DCE-MRI.

Christine Ellingsen1, Stefan Walenta, Tord Hompland, Wolfgang Mueller-Klieser, Einar K Rofstad.   

Abstract

Poor disease-free and overall survival rates in locally advanced cervical cancer are associated with a tumor micro-environment characterized by extensive hypoxia, interstitial hypertension, and high lactate concentrations. The potential of gadolinium diethylenetriamine pentaacetic acid-based dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in assessing the microenvironment and microenvironment-associated aggressiveness of cervical carcinomas was investigated in this preclinical study. CK-160 and TS-415 cervical carcinoma xenografts were used as tumor models. DCE-MRI was carried out at 1.5 T, and parametric images of K (trans) and v e were produced by pharmacokinetic analysis of the DCE-MRI series. Pimonidazole was used as a marker of hypoxia. A Millar catheter was used to measure tumor interstitial fluid pressure (IFP). The concentrations of glucose, adenosine triphosphate (ATP), and lactate were measured by induced metabolic bioluminescence imaging. High incidence of lymph node metastases was associated with high hypoxic fraction and high lactate concentration in CK-160 tumors and with high IFP and high lactate concentration in TS-415 tumors. Low K (trans) was associated with high hypoxic fraction, low glucose concentration, and high lactate concentration in tumors of both lines and with high incidence of metastases in CK-160 tumors. Associations between v e and microenvironmental parameters or metastatic propensity were not detected in any of the tumor lines. Taken together, this preclinical study suggests that K (trans) is a potentially useful biomarker for poor outcome of treatment in advanced cervical carcinoma. The possibility that K (trans) may be used to identify patients with cervical cancer who are likely to benefit from particularly aggressive treatment merits thorough clinical investigations.

Entities:  

Year:  2013        PMID: 24151541      PMCID: PMC3799202          DOI: 10.1593/tlo.13313

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  60 in total

Review 1.  Locally advanced cervical cancer: what is the standard of care?

Authors:  Zeina Al-Mansour; Claire Verschraegen
Journal:  Curr Opin Oncol       Date:  2010-09       Impact factor: 3.645

Review 2.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

Authors:  Nola Hylton
Journal:  J Clin Oncol       Date:  2006-07-10       Impact factor: 44.544

Review 3.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

4.  Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements.

Authors:  M Milosevic; A Fyles; D Hedley; M Pintilie; W Levin; L Manchul; R Hill
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 5.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 6.  Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.

Authors:  J Green; J Kirwan; J Tierney; C Vale; P Symonds; L Fresco; C Williams; M Collingwood
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

7.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

Review 8.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

Review 9.  Management of early and locally advanced cervical cancer.

Authors:  Lisa Barbera; Gillian Thomas
Journal:  Semin Oncol       Date:  2009-04       Impact factor: 4.929

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  9 in total

1.  Toward a noninvasive estimate of interstitial fluid pressure by dynamic contrast-enhanced MRI in a rat model of cerebral tumor.

Authors:  Rasha Elmghirbi; Tavarekere N Nagaraja; Stephen L Brown; Kelly A Keenan; Swayamprava Panda; Glauber Cabral; Hassan Bagher-Ebadian; George W Divine; Ian Y Lee; James R Ewing
Journal:  Magn Reson Med       Date:  2018-03-09       Impact factor: 4.668

2.  Feasibility of induced metabolic bioluminescence imaging in advanced ovarian cancer patients: first results of a pilot study.

Authors:  Marco Johannes Battista; Kristina Goetze; Marcus Schmidt; Cristina Cotarelo; Veronika Weyer-Elberich; Annette Hasenburg; Wolfgang Mueller-Klieser; Stefan Walenta
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-24       Impact factor: 4.553

3.  Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.

Authors:  Mengmeng Niu; Youssef W Naguib; Abdulaziz M Aldayel; Yan-chun Shi; Stephen D Hursting; Matthew A Hersh; Zhengrong Cui
Journal:  Mol Pharm       Date:  2014-10-27       Impact factor: 4.939

4.  E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.

Authors:  Rong Zhang; Huan Lu; Yuan-Yuan Lyu; Xiao-Mei Yang; Lin-Yan Zhu; Guang-Dong Yang; Peng-Cheng Jiang; Yuan Re; Wei-Wei Song; Jin-Hao Wang; Can-Can Zhang; Fei Gu; Tian-Jiao Luo; Zhi-Yong Wu; Cong-Jian Xu
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

5.  Intratumor Heterogeneity in Interstitial Fluid Pressure in Cervical and Pancreatic Carcinoma Xenografts.

Authors:  Lise Mari K Hansem; Ruixia Huang; Catherine S Wegner; Trude G Simonsen; Jon-Vidar Gaustad; Anette Hauge; Einar K Rofstad
Journal:  Transl Oncol       Date:  2019-06-04       Impact factor: 4.243

Review 6.  Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy.

Authors:  Heidi Espedal; Tina Fonnes; Kristine E Fasmer; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

7.  Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS.

Authors:  Saurabh S Gorad; Christine Ellingsen; Tone F Bathen; Berit S Mathiesen; Siver A Moestue; Einar K Rofstad
Journal:  Neoplasia       Date:  2015-10       Impact factor: 5.715

8.  Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.

Authors:  Christine Ellingsen; Lise Mari K Andersen; Kanthi Galappathi; Einar K Rofstad
Journal:  BMC Cancer       Date:  2015-10-26       Impact factor: 4.430

9.  DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.

Authors:  Anette Hauge; Catherine S Wegner; Jon-Vidar Gaustad; Trude G Simonsen; Lise Mari K Andersen; Einar K Rofstad
Journal:  J Transl Med       Date:  2017-11-03       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.